Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses

被引：43
作者：
Xia, Pu [1 ]
Xu, Xiao-Yan [2 ]
机构：
[1] Liaoning Med Univ, Coll Basic Med Sci, Dept Cell Biol, Jinzhou, Liaoning, Peoples R China
[2] China Med Univ, Coll Basic Med Sci, Dept Pathophysiol, Shenyang, Liaoning, Peoples R China
来源：
ONCOTARGET | 2016年 / 7卷 / 29期
关键词：
CD44; the cancer genome atlas; gastric cancer; colon cancer; bioinformatic analyses; STEM-CELL MARKER; COLORECTAL-CANCER; EXPRESSION; CARCINOMA; CD133; CD74; METAANALYSIS; ASSOCIATION; RECURRENCE; ISOFORMS;
D O I：
10.18632/oncotarget.9998
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CD44 is a well-recognized stem cell biomarker expressed in colon and gastric cancer. In order to identify whether CD44 mRNA could be used as a prognostic marker in colon and gastric cancer, bioinformatic analyses were used in this study. cBioPortal analysis and COSMIC analysis were used to explore the CD44 mutation. CD44 mRNA levels were evaluated by using SAGE Genie tools and Oncomine analysis. Kaplan-Meier Plotter was performed to identify the prognostic roles of CD44 mRNA in these two cancers. In this study, first, we found that low alteration frequency of CD44 mRNA in colon and gastric cancer. Second, the high CD44 mRNA level was found in colon and gastric cancer, and it correlated with a benign survival rate in gastric cancer. Third, CD4 and CD74 may be used as markers to predict the prognosis of colon and gastric cancer. However, the deep mechanism(s) of these results remains unclear, further studies have to be performed in the future.
引用
收藏
页码：45538 / 45546
页数：9
相关论文
共 33 条
[1]   The epigenetics of tumour initiation: cancer stem cells and their chromatin [J].
Avgustinova, Alexandra ;
Aznar Benitah, Salvador .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2016, 36 :8-15
[2]   CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease [J].
Borghese, Federica ;
Clanchy, Felix I. L. .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (03) :237-251
[3]   Key roles of hyaluronan and its CD44 receptor in the sternness and survival of cancer stern cells [J].
Chanmee, Theerawut ;
Ontong, Pawared ;
Kimata, Koji ;
Nano, Naoki .
FRONTIERS IN ONCOLOGY, 2015, 5
[4]   Clinicopathologic Significance of Putative Stem Cell Marker, CD44 and CD133, in Human Gastric Carcinoma [J].
Chen, Shi ;
Hou, Jing-Hui ;
Feng, Xing-Yu ;
Zhang, Xiao-Shi ;
Zhou, Zhi-Wei ;
Yun, Jing-Ping ;
Chen, Ying-Bo ;
Cai, Mu-Yan .
JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (08) :799-806
[5]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[6]   CD74 expression and its therapeutic potential in thyroid carcinoma [J].
Cheng, Shih-Ping ;
Liu, Chien-Liang ;
Chen, Ming-Jen ;
Chien, Ming-Nan ;
Leung, Ching-Hsiang ;
Lin, Chi-Hsin ;
Hsu, Yi-Chiung ;
Lee, Jie-Jen .
ENDOCRINE-RELATED CANCER, 2015, 22 (02) :179-190
[7]   CD44 Gene Polymorphisms and Environmental Factors on Oral Cancer Susceptibility in Taiwan [J].
Chou, Ying-Erh ;
Hsieh, Ming-Ju ;
Hsin, Chung-Han ;
Chiang, Whei-Ling ;
Lai, Yi-Cheng ;
Lee, Yu-Hsien ;
Huang, Shu-Ching ;
Yang, Shun-Fa ;
Lin, Chiao-Wen .
PLOS ONE, 2014, 9 (04)
[8]  
FOX SB, 1994, CANCER RES, V54, P4539
[9]   Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence [J].
Gerger, Armin ;
Zhang, Wu ;
Yang, Dongyun ;
Bohanes, Pierre ;
Ning, Yan ;
Winder, Thomas ;
LaBonte, Melissa J. ;
Wilson, Peter M. ;
Benhaim, Leonor ;
Paez, David ;
El-Khoueiry, Rita ;
El-Khoueiry, Anthony ;
Kahn, Michael ;
Lenz, Heinz-Josef .
CLINICAL CANCER RESEARCH, 2011, 17 (21) :6934-6943
[10]   Collaboration between tumor-specific CD4+ T cells and B cells in anti-cancer immunity [J].
Guy, Thomas V. ;
Terry, Alexandra M. ;
Bolton, Holly A. ;
Hancock, David G. ;
Zhu, Erhua ;
Brink, Robert ;
McGuire, Helen M. ;
Shklovskaya, Elena ;
Fazekas de St Groth, Barbara .
ONCOTARGET, 2016, 7 (21) :30211-30229
1234